3 Canadian Healthcare Stocks Thriving in a Down Market

The Canadian healthcare stocks on our list have surged 177% on average over the past three months while the TSX has slumped

SmallCapPower | April 4, 2018: The Canadian healthcare sector is struggling, with the S&P/TSX Capped Healthcare Index declining 14% over the past three months while the Dow Jones Healthcare Index decreased 4%. In contrast, the TSX is down 8% while the Dow Jones has eased 5%. However, the Canadian healthcare stocks on our list today have seen strong returns despite poor sector performance, and could continue to rise, especially if the sector recovers.

Biocure Technology Inc. (CSE:CURE) – $1.14
Pharmaceuticals

Biocure Technology is a U.S.-based pharmaceutical company. The Company’s primary product is its in-situ polymerizing hydrogels, used in dressings, tissue adhesives, and other applications. Biocure also offers block copolymers, designed to mimic biological cell membranes.

  • Market Cap: $49.5 Million
  • 1 Month Total Return: 15.2%
  • 3 Month Total Return: 250.8%

Antibe Therapeutics Inc. (TSXV:ATE) – $0.46
Biotechnology & Medical Research

Antibe Therapeutics is a Canada-based biotech company with several products in development. The Company’s drug division produces ATB-346, a Non-Steroidal Anti-Inflammatory Drug (NSAID), with minimal GI damage and effect on blood pressure. Its Citagenix subsidiary produces dental regenerative medicine for oral surgery.

  • Market Cap: $80.4 Million
  • 1 Month Total Return: 75.0%
  • 3 Month Total Return: 160.0%
  • 52 Week Total Return: 127.5%

ProMIS Neurosciences Inc. (TSX:PMN) – $0.46
Biotechnology & Medical Research

ProMIS is a Canada-based biotech company focused on treating neurodegenerative diseases. The Company has seven products in development, four of which target Alzheimer’s, two which target ALS, and one which targets Parkinson’s. ProMIS aims to treat misfolded proteins, using a molecular target identification system licensed from UBC.

  • Market Cap: $104.1 Million
  • 1 Month Total Return: 27.8%
  • 3 Month Total Return: 119.0%

Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.

To read our full disclosure, please click on the button below: